|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for ELOVL6 |
Basic gene info. | Gene symbol | ELOVL6 |
Gene name | ELOVL fatty acid elongase 6 | |
Synonyms | FACE|FAE|LCE | |
Cytomap | UCSC genome browser: 4q25 | |
Genomic location | chr4 :110970228-111119771 | |
Type of gene | protein-coding | |
RefGenes | NM_001130721.1, NM_024090.2, | |
Ensembl id | ENSG00000170522 | |
Description | 3-keto acyl-CoA synthase ELOVL6ELOVL FA elongase 6ELOVL family member 6, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast)elongation of very long chain fatty acids protein 6fatty acid elongase 2fatty acyl-CoA elongasehELO2long | |
Modification date | 20141207 | |
dbXrefs | MIM : 611546 | |
HGNC : HGNC | ||
Ensembl : ENSG00000170522 | ||
HPRD : 13269 | ||
Vega : OTTHUMG00000132547 | ||
Protein | UniProt: go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ELOVL6 | |
BioGPS: 79071 | ||
Gene Expression Atlas: ENSG00000170522 | ||
The Human Protein Atlas: ENSG00000170522 | ||
Pathway | NCI Pathway Interaction Database: ELOVL6 | |
KEGG: ELOVL6 | ||
REACTOME: ELOVL6 | ||
ConsensusPathDB | ||
Pathway Commons: ELOVL6 | ||
Metabolism | MetaCyc: ELOVL6 | |
HUMANCyc: ELOVL6 | ||
Regulation | Ensembl's Regulation: ENSG00000170522 | |
miRBase: chr4 :110,970,228-111,119,771 | ||
TargetScan: NM_001130721 | ||
cisRED: ENSG00000170522 | ||
Context | iHOP: ELOVL6 | |
cancer metabolism search in PubMed: ELOVL6 | ||
UCL Cancer Institute: ELOVL6 | ||
Assigned class in ccmGDB | C |
Top |
Phenotypic Information for ELOVL6(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: ELOVL6 |
Familial Cancer Database: ELOVL6 |
* This gene is included in those cancer gene databases. |
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS |
Others | |
OMIM | |
Orphanet | |
Disease | KEGG Disease: ELOVL6 |
MedGen: ELOVL6 (Human Medical Genetics with Condition) | |
ClinVar: ELOVL6 | |
Phenotype | MGI: ELOVL6 (International Mouse Phenotyping Consortium) |
PhenomicDB: ELOVL6 |
Mutations for ELOVL6 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
- Statistics for Tissue and Mutation type | Top |
- For Inter-chromosomal Variations |
* Inter-chromosomal variantions includes 'interchromosomal amplicon to amplicon', 'interchromosomal amplicon to non-amplified dna', 'interchromosomal insertion', 'Interchromosomal unknown type'. |
- For Intra-chromosomal Variations |
* Intra-chromosomal variantions includes 'intrachromosomal amplicon to amplicon', 'intrachromosomal amplicon to non-amplified dna', 'intrachromosomal deletion', 'intrachromosomal fold-back inversion', 'intrachromosomal inversion', 'intrachromosomal tandem duplication', 'Intrachromosomal unknown type', 'intrachromosomal with inverted orientation', 'intrachromosomal with non-inverted orientation'. |
Sample | Symbol_a | Chr_a | Start_a | End_a | Symbol_b | Chr_b | Start_b | End_b |
ovary | ELOVL6 | chr4 | 111021528 | 111021728 | ELOVL6 | chr4 | 111008400 | 111008600 |
pancreas | ELOVL6 | chr4 | 110976553 | 110976573 | chr10 | 31957573 | 31957593 | |
pancreas | ELOVL6 | chr4 | 110999600 | 110999620 | ELOVL6 | chr4 | 111000667 | 111000687 |
pancreas | ELOVL6 | chr4 | 110999600 | 110999620 | ELOVL6 | chr4 | 111000672 | 111000692 |
cf) Tissue number; Tissue name (1;Breast, 2;Central_nervous_system, 3;Haematopoietic_and_lymphoid_tissue, 4;Large_intestine, 5;Liver, 6;Lung, 7;Ovary, 8;Pancreas, 9;Prostate, 10;Skin, 11;Soft_tissue, 12;Upper_aerodigestive_tract) |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows ELOVL6 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample |   |   |   | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   | |||
GAIN (# sample) |   |   |   | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   | |||
LOSS (# sample) |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=24) | (# total SNVs=3) |
(# total SNVs=0) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr4:111026726-111026726 | p.L50V | 2 |
chr4:111119394-111119394 | p.? | 2 |
chr4:111119479-111119479 | p.V5L | 1 |
chr4:110972602-110972602 | p.Q230H | 1 |
chr4:110972803-110972803 | p.G163G | 1 |
chr4:110980907-110980907 | p.I75I | 1 |
chr4:110972631-110972631 | p.Q221* | 1 |
chr4:110972820-110972820 | p.D158N | 1 |
chr4:111026713-111026713 | p.R54P | 1 |
chr4:110972636-110972636 | p.W219* | 1 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample | 1 | 3 | 1 | 4 |   |   | 2 |   |   | 1 |   | 2 | 1 | 1 |   | 1 | 4 |   |   | 5 |
# mutation | 1 | 3 | 1 | 4 |   |   | 2 |   |   | 1 |   | 2 | 1 | 1 |   | 1 | 4 |   |   | 5 |
nonsynonymous SNV | 1 | 3 |   | 4 |   |   | 1 |   |   | 1 |   | 2 | 1 | 1 |   |   | 2 |   |   | 3 |
synonymous SNV |   |   | 1 |   |   |   | 1 |   |   |   |   |   |   |   |   | 1 | 2 |   |   | 2 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr4:110972668 | p.A175D,ELOVL6 | 1 |
chr4:110980893 | p.F13F,ELOVL6 | 1 |
chr4:110972698 | p.V173V,ELOVL6 | 1 |
chr4:110980902 | p.V5L,ELOVL6 | 1 |
chr4:110972768 | p.G163G,ELOVL6 | 1 |
chr4:111026713 | p.V117L,ELOVL6 | 1 |
chr4:110972773 | p.F111L,ELOVL6 | 1 |
chr4:111026722 | p.S109R,ELOVL6 | 1 |
chr4:110972803 | p.S97S,ELOVL6 | 1 |
chr4:111026731 | p.Q96K,ELOVL6 | 1 |
Other DBs for Point Mutations |
Copy Number for ELOVL6 in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for ELOVL6 |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
ABCE1,ARHGAP11A,BUB1B,KNSTRN,CENPE,CISD2,DARS2, EIF4E,ELOVL6,GABRA5,H2AFZ,KPNA2,KRT34,LIN54, MAD2L1,METAP1,MRPL19,NAA15,NEIL3,PAICS,PNPT1 | ACLY,ANO3,C8orf34,CDKN2C,CPA2,DLAT,ECHDC1, ELOVL6,FADS1,RMDN3,FLJ43390,GPR50,LOC285370,ME1, MMP17,NKX2-4,OLFM2,SCD,SEL1L2,SPZ1,TMEM132B |
GDPGP1,CDS1,DHCR24,ELOVL6,F2RL1,FDFT1,FDPS, HK2,HMGCR,HMGCS1,LIMA1,LPIN1,PAPSS2,PNP, RBM47,RDH11,RNF145,MSMO1,SFXN1,SIAE,SLC37A1 | ANKRD22,C4BPB,DNAJB11,EIF2B2,EIF4A1,EIF5AL1,ELOVL6, ERI1,FGFBP1,GGCT,HM13,MANF,MMP1,NME1, PDIA6,RPN1,SDF2L1,SLC6A14,TIMM17A,TMED9,UBXN8 |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for ELOVL6 |
There's no related Drug. |
Top |
Cross referenced IDs for ELOVL6 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |